Axiom Investors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8M Sell
153,644
-14,572
-9% -$1.2M 0.14% 61
2025
Q4
$15.4M Buy
168,216
+16,819
+11% +$1.61M 0.14% 65
2025
Q3
$14.3M Buy
151,397
+27,128
+22% +$2.55M 0.11% 77
2025
Q2
$13M Buy
124,269
+30,615
+33% +$2.9M 0.11% 59
2025
Q1
$8.28M Buy
+93,654
New +$9.61M 0.08% 80
2020
Q2
Sell
-49,120
Closed -$2.48M 121
2020
Q1
$2.48M Buy
49,120
+9,567
+24% +$635K 0.06% 85
2019
Q4
$2.93M Buy
39,553
+14,352
+57% +$895K 0.07% 93
2019
Q3
$1.44M Buy
+25,201
New +$1.67M 0.04% 105
2017
Q3
Sell
-72,985
Closed -$3.64M 142
2017
Q2
$3.64M Buy
72,985
+15,517
+27% +$726K 0.09% 103
2017
Q1
$2.44M Buy
+57,468
New +$2.54M 0.06% 108

Other funds holding HQY

Axiom Investors's HQY Position: Q1 2026 in Review

Axiom Investors reduced its HealthEquity (HQY) stake by 8.7% in Q1 2026, selling an estimated $1.2M and leaving 153,644 shares worth $12.8M. The position accounts for 0.14% of the portfolio, ranked #61.

Axiom Investors first reported a position in HQY in Q1 2017 and has held it in 10 quarters since. The position peaked at $15.4M in Q4 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Axiom Investors held 153,644 shares of HealthEquity worth $12.8M as of Q1 2026.
  • Axiom Investors sold 14,572 HealthEquity shares in Q1 2026, an estimated $1.2M.
  • HealthEquity made up 0.14% of Axiom Investors's portfolio in Q1 2026, its #61 holding.
  • Axiom Investors first reported a position in HealthEquity in Q1 2017 and has held it in 10 quarters since.
  • Axiom Investors's HealthEquity position peaked at $15.4M in Q4 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Axiom Investors's 13F filing for Q1 2026, filed 14 May 2026.